Diaminopropanoic Acid

Diaminopropanoic Acid

SCHEMBL5548529

Br.NCC(N)C(=O)O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Diaminopropanoic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5757408-A PRINTING IMAGE ON SUBSTRATE COATED WITH AMINO-ACID DERIVATIVE ADDITIVE; QUICK DRYING OF INK, OPTICAL DENSITY, NONCURLING XEROX CORPORATION (US) 1998-05-26 US claimed
US-5683793-A Ink jet transparencies XEROX CORPORATION (US) 1997-11-04 US claimed
US-5589277-A INK JET PRINTING, AQUEOUS INKS, FAST DRYING XEROX CORPORATION (US) 1996-12-31 US claimed
EP-0667246-A1 Recording sheets containing amino acids, hydroxy acids, and polycarboxyl compounds XEROX CORPORATION (US) 1995-08-16 EP claimed
JP-63060959-A None JP disclosed
US-12098147-B2 Compound having novel structure, complex comprising same, anti-cancer pharmaceutical composition, and anti-cancer drug ETNOVA THERAPEUTICS CORP. (KR) 2024-09-24 US disclosed
CN-112533907-B Compounds having novel structures, complexes comprising same, and anti-cancer pharmaceutical compositions and anti-cancer agents 艾特诺瓦治疗公司 2024-02-06 CN disclosed
US-20220024911-A1 COMPOUND HAVING NOVEL STRUCTURE, COMPLEX COMPRISING SAME, ANTI-CANCER PHARMACEUTICAL COMPOSITION, AND ANTI-CANCER DRUG ETNOVA THERAPEUTICS CORP. (KR) 2022-01-27 US disclosed
CN-112533907-A Compound having novel structure, complex comprising same, pharmaceutical composition for anticancer use, and anticancer agent 未来生物医药公司 2021-03-19 CN disclosed
EP-3792253-A1 COMPOUND HAVING NOVEL STRUCTURE, COMPLEX COMPRISING SAME, ANTI-CANCER PHARMACEUTICAL COMPOSITION, AND ANTI-CANCER DRUG Miraebiopharm (KR) 2021-03-17 EP disclosed
WO-2019216653-A1 COMPOUND HAVING NOVEL STRUCTURE, COMPLEX COMPRISING SAME, ANTI-CANCER PHARMACEUTICAL COMPOSITION, AND ANTI-CANCER DRUG 경북대학교 산학협력단 (KR) 2019-11-14 WO disclosed
US-20070129371-A1 Novel ethylenediamine derivatives DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-06-07 US disclosed
EP-0751765-A1 SULFONAMIDE DERIVATIVES AND THEIR USE PHARMACOPEIA, INC. (US) 1997-01-08 EP disclosed
WO-1996039137-A1 INHIBITORS OF FARNESYL-PROTEIN TRANSFERASE MERCK & CO., INC. (US) 1996-12-12 WO disclosed
WO-1995024186-A1 SULFONAMIDE DERIVATIVES AND THEIR USE PHARMACOPEIA, INC. (US) 1995-09-14 WO disclosed
WO-1992002513-A1 HETEROCYCLIC COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-02-20 WO disclosed
JP-S6360959-A DIAMINOPROPIONIC ACID DERIVATIVE OR SALT THEREOF MITSUBISHI CHEM IND LTD 1988-03-17 JP disclosed
US-4463173-A ANTIBIOTIC, BACTERICIDE ICI PHARMA (FR) 1984-07-31 US disclosed
EP-0031708-B1 CEPHALOSPORIN DERIVATIVES, PROCESSES FOR THEIR MANUFACTURE, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND INTERMEDIATES THEREFOR ICI PHARMA (FR) 1984-06-13 EP disclosed
EP-0031708-A2 Cephalosporin derivatives, processes for their manufacture, pharmaceutical compositions containing them and intermediates therefor ICI PHARMA (FR) 1981-07-08 EP disclosed